Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 20, 2025 16:50 ET | Source: Larkspur Biosciences, Inc.

Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting

Larkspur Biosciences Announces Discovery of LRK-4189, 1st-in-Class Degrader of Lipid Kinase PIP4K2C, for Treatment of MSS CRC at ACS Fall 2025 Meeting
August 18, 2025 08:30 ET | Source: Biodexa Pharmaceuticals PLC

Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)

August 18, 2025 Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Opportunity to be First Mover in $7.3Bn Addressable Market ...
August 13, 2025 16:05 ET | Source: Immuneering Corporation

Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates

Immuneering Reports Second Quarter 2025 Financial Results and Provides Business Updates
June 12, 2025 14:32 ET | Source: Fight Colorectal Cancer

Private Donors Give $350,000 To Precision Medicine Study for Colorectal Cancer Patients

Springfield, Mo., June 12, 2025 (GLOBE NEWSWIRE) -- Philanthropic support from private donors is what’s helping fund a new study focused on advancing precision medicine for metastatic colorectal...
June 06, 2025 14:41 ET | Source: Fight Colorectal Cancer

First Ascent Biomedical and Fight Colorectal Cancer Announce Groundbreaking Study to Advance Precision Oncology for Colorectal Cancer Patients

Springfield, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- First Ascent Biomedical (FA), an innovative biotech company specializing in transforming cancer treatment through functional precision medicine,...
June 05, 2025 09:26 ET | Source: Research and Markets

Global Oncology Collaboration and Licensing Deals Report 2020-2025: 3,350 Biopharma Agreements Analyzed with Financial Terms, Partnering Trends, and Contract Insights

Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Oncology Collaboration and Licensing Deals 2020-2025" report has been added to ResearchAndMarkets.com's offering.Oncology Collaboration and Licensing...
June 03, 2025 11:50 ET | Source: Research and Markets

United States Oncology Information Systems Market Report 2025-2030 Featuring Elekta, Accuray, RaySearch Laboratories, Cerner, BrainLab, Philips Healthcare, Prowess, DOSIsoft, ViewRay, & MIM Software

Dublin, June 03, 2025 (GLOBE NEWSWIRE) -- The "United States Oncology Information Systems Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to ...
May 29, 2025 08:00 ET | Source: Immuneering Corporation

Immuneering to Present at the Jefferies Global Healthcare Conference

Immuneering to Present at the Jefferies Global Healthcare Conference
May 27, 2025 13:32 ET | Source: Fight Colorectal Cancer

Global Experts from 23 Countries Convene in Barcelona to Confront Rising Rates of Early Onset Colorectal Cancer

Springfield, Mo., May 27, 2025 (GLOBE NEWSWIRE) -- Fight Colorectal Cancer (Fight CRC), in partnership with Dr. José Perea of the Instituto de Investigación Biomédica de Salamanca (IBSAL) and a...
May 20, 2025 02:30 ET | Source: Exact Therapeutics AS

EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer

These results indicate that EXACT Therapeutics’ Acoustic Cluster Therapy (ACT®) significantly enhances the local effect of chemotherapyIn the patients who had a response to chemotherapy, ACT-treated...